# Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients

> **NCT00494949** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sangart** · enrollment: 30 (actual)

## Conditions studied

- Hypotension
- Hypoxia

## Interventions

- **DRUG:** Hemospan (MP4OX)
- **DRUG:** Ringer's lactate

## Key facts

- **NCT ID:** NCT00494949
- **Lead sponsor:** Sangart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-07
- **Final completion:** 2006-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00494949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00494949, "Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00494949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*